Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFuture Regulatory News (FUTR)

Share Price Information for Future (FUTR)

Share Price is delayed by 15 minutes
Get Live Data
302.60    4.20 (1.41%)
Bid:
301.20
Ask:
302.00
Spread: 0.80 (0.266%)
Market Cap: £272.17m
FUTR Live PriceLast checked at - London Stock Exchange

Intraday Future Share Chart

Director/PDMR Shareholding

13 Dec 2024 10:34

RNS Number : 0545Q
Future PLC
13 December 2024
 

Date: 13 December 2024

 

 

 

Future plc

(the "Company")

 

Director/PDMR holding

 

 

Performance Share Plan (PSP)

On 12 December 2024, in accordance with the provisions of the Company's approved Remuneration Policy, an award was made of the following nil-cost options over Ordinary Shares of 15p each in the Company ("Shares") under the terms of the Future plc 2023 Performance Share Plan ("PSP"). This award will normally vest on the third anniversary of grant. The award under the PSP is subject to performance conditions (as set out on page 102 of the Company's Annual Report & Accounts for FY2024) and a holding period applies to the Executive Directors from the vesting date in respect of any Shares which vest under this award.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

Sharjeel Suleman

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

 

Chief Financial Officer (PDMR)

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

 

Future plc

b)

 

LEI

 

 

 

213800K2581YRLEXV353

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 15p each

Identification code

GB00BYZN9041

b)

 

Nature of the transaction

 

 

Grant of nil cost options over Future plc Shares under the PSP. The award will vest on the third anniversary of the date of grant, subject to the performance conditions, relating to the Company's relative TSR, adjusted diluted EPS and organic revenue growth for the year ended 30 September 2027, as are set out on page 102 of the Company's Annual Report & Accounts for FY2024.

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

70,705

d)

 

Aggregated information

N/A (single transaction)

- Aggregated volume

- Price

e)

 

Date of the transaction

 

12 December 2024

f)

 

Place of the transaction

 

London

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBGBDDDXBDGSX
Date   Source Headline
22nd May 202310:32 amRNSHolding(s) in Company
19th May 20237:00 amRNSDirector/PDMR Shareholding
18th May 20237:00 amRNS2023 Interim Year Results
2nd May 20233:16 pmRNSTotal Voting Rights
4th Apr 202310:06 amRNSCEO Appointment
3rd Apr 20235:12 pmRNSTotal Voting Rights and Share Capital
30th Mar 20233:20 pmRNSDirector Declaration
30th Mar 20237:00 amRNSCompany Secretary Change
13th Mar 20237:00 amRNSNo material exposure to Silicon Valley Bank
1st Mar 202310:04 amRNSTotal Voting Rights
1st Mar 20237:00 amRNSHolding(s) in Company
22nd Feb 20237:00 amRNSAppointment of Jon Steinberg as CEO
14th Feb 20234:35 pmRNSHolding(s) in Company
14th Feb 20237:00 amRNSDirector/PDMR Shareholding
8th Feb 20231:51 pmRNSResult of AGM
8th Feb 20237:00 amRNSAGM trading statement
7th Feb 20232:39 pmRNSHolding(s) in Company
3rd Feb 202311:10 amRNSHolding(s) in Company
31st Jan 20231:40 pmRNSTotal Voting Rights
11th Jan 20231:41 pmRNSHolding(s) in Company
5th Jan 20237:00 amRNSEBT share purchase
3rd Jan 20232:35 pmRNSHolding(s) in Company
3rd Jan 20232:27 pmRNSBlock listing Interim Review
30th Dec 20227:00 amRNSTotal Voting Rights
19th Dec 20227:00 amRNSDirector/PDMR Shareholding
15th Dec 202210:51 amRNSAnnual Financial Report
7th Dec 20227:00 amRNSDirector/PDMR Shareholding
30th Nov 20229:57 amRNSTotal Voting Rights
30th Nov 20227:00 amRNSFull Year Results
3rd Nov 202212:23 pmRNSDirector Declaration
31st Oct 20229:32 amRNSTotal Voting Rights
3rd Oct 20227:00 amRNSTotal Voting Rights
28th Sep 20222:16 pmRNSHolding(s) in Company
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
20th Sep 202210:35 amRNSResponse to press speculation
15th Sep 20227:14 amRNSDirector Declaration
14th Sep 20227:00 amRNSCapital Market Event
13th Sep 20227:00 amRNSTrading Update
12th Sep 20227:00 amRNSDirector/PDMR Shareholding
31st Aug 20229:35 amRNSTotal Voting Rights
8th Aug 20228:32 amRNSHolding(s) in Company
2nd Aug 20227:00 amRNSNotice of Capital Markets Event
29th Jul 20227:00 amRNSTotal Voting Rights
30th Jun 20228:27 amRNSTotal Voting Rights
30th Jun 20228:25 amRNSBlock listing Interim Review
17th Jun 20227:00 amRNSCompletion of Acquisition & Trading update
15th Jun 20221:19 pmRNSEBT share purchase
31st May 20228:24 amRNSTotal Voting Rights
25th May 20223:13 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.